Equibles does not estimate personal net worth.
Get an email with a short summary when Cellectar Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get CLRB alertsJim Caruso is recorded as CEO at Cellectar Biosciences, Inc. (CLRB). Jim Caruso has spoken on 7 earnings calls across 1 company, most recently for Cellectar Biosciences, Inc. on May 14, 2026. Cellectar Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cellectar Biosciences, Inc. includes James Caruso (CEO and Board Member), James V. Caruso (CEO and Board Member), Douglas J. Swirsky (Chairman and Board Member) and 7 others.
“The first quarter of 2026 marked a transformational period for SelectAR, defined by rigorous execution across our clinical, regulatory, and financial strategies.”
“Thank you, Anne-Marie, and thank you all for joining us this morning as we review Select Ours' progress throughout the year. 2025 was a productive and strategically meaningful year for SelectArm.”
“Thank you, Anne Marie, and thanks to all participants for joining us this morning as we review Cellectar Biosciences, Inc.'s progress in 2025.”
“Thank you, Anne Marie, and thank you all for joining us this morning as we review the progress Cellectar has made throughout the first quarter of 2025.”
“Thank you, Anne Marie, and thank you to all for joining us this morning as we share Cellectar's recent regulatory progress with iopofosine, our ongoing preparations to advance our Alpha and Auger radioisotopes solid tumor programs, and forward-looking plans to address the Company's NASDAQ status and future funding…”
Biotechnology · Healthcare
CEO
